ZNF335 plays an essential role in neurogenesis and biallelic variants in ZNF335 have been identified as the cause of severe primary autosomal recessive microcephaly in 2 unrelated families. 
Funding information

| Patient B
Patient B is the second child of non-consanguineous parents of Caucasian European descent. Family history is negative for microcephaly, and positive for mother with miscarriage at 8 weeks, maternal uncle with a fatty acid oxidation defect, and paternal cousin with autism.
Patient B was born at 39 weeks after an uncomplicated pregnancy. (Arg571His) VUS.
| Variant analysis
The homozygous p.(Cys467Arg) variant in patient A is located at a highly conserved zinc finger domain, and is predicted to be pathogenic by SIFT, PolyPhen-2 and MutationTaster. The cysteine to arginine substitution is likely to be deleterious because it changes a thiol (uncharged residue) to a positively charged residue. Moreover, the p.
(Cys467Arg) allele is absent from more than 138 000 individuals in the gnomAD Consortium. 3 The heterozygous c.3998A > G, p.
(Glu1333Gly) variant in patient B is located at an amino acid conserved throughout mammals in the C-terminal portion of ZNF335 that is integral for interacting with DBC-1. 4 This variant is predicted to be damaging (SIFT), probably damaging (Polyphen-2) or disease causing (MutationTaster) and is rare, seen in a heterozygous state in 31 individuals in gnomAD consortium, with an allele frequency of 0.01119% and no homozygotes. ).
The degree of microcephaly at birth was variable between patients (Table 1) (Glu1333Gly) variant in gnomAD suggests that milder cases of this condition caused by compound heterozygotes with this variant, as seen in patient B, may be more prevalent than previously recognized.
